veINS Track: Don’t Wait for a Mandate for PIVC Infection Surveillance
Recorded On: 06/06/2022
Hospitals have been collecting data on central line associated complications, most notably central line associated bloodstream infections (CLABSI) for many years; however, many do not include PIVC infection surveillance in their scope. Although not yet mandated in the United States at the federal level, clinicians are encouraged to review strategies for collecting and reporting this data to help drive progress in improving safety across all vascular access and infusion activities to enhance vessel health and preservation. In this session, we will review the current literature on PIVC-related infections and complications, discuss strategies for conducting surveillance, and explain how to use of the data to improve patient outcomes.
Learning Objectives: At the conclusion of this session, learners will be able to:
· Describe the current literature on PIVC-related infections and other complications
· Discuss strategies for conducting surveillance on PIVC infections
· Explain how to use the surveillance data to advocate for your patients
Chellie DeVries has been involved in infection prevention and hospital epidemiology for more than 25 years, spanning community, university and federal health care facilities. She is particularly passionate about raising awareness around peripheral vascular access devices and devotes her time to education on this topic throughout the United States and internationally. She was a reviewer for the 2016 and 2021 INS Infusion Therapy Standards of Practice, is serving on the 2024 Standards of Practice Committee, and has authored several textbook chapters as well as numerous peer-reviewed journal articles. She is an adjunct research fellow with AVATAR and serves as the secretary for the Association for Vascular Access (AVA).